A Single Procalcitonin Level Does Not Predict Adverse Outcomes of Women with Pyelonephritis

European Urology

Volumn 51, Issue 5, 2007, Pages 1394-1401

  Lemiale, Virginie ^a   Renaud, Bertrand ^a   Moutereau, Stéphane ^a   N'Gako, Alfred ^a   Salloum, Mirna ^a   Calmettes, Marie Jeanne ^a   Hervé, Jérôme ^a   Boraud, Cyril ^a   Santin, Aline ^a   Grégo, Jean Claude ^a   Braconnier, François ^a   Roupie, Eric ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

Emergency medicine; Hospitalization; Outcome; Prediction; Procalcitonin; Pyelonephritis

Indexed keywords

BIOLOGICAL MARKER; PROCALCITONIN;

ADULT; ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; EMERGENCY WARD; FEMALE; FRANCE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PYELONEPHRITIS; SENSITIVITY AND SPECIFICITY; WOMEN'S HEALTH;

ACUTE DISEASE; ADULT; BIOLOGICAL MARKERS; CALCITONIN; FEMALE; HOSPITALIZATION; HUMANS; MIDDLE AGED; PROTEIN PRECURSORS; PYELONEPHRITIS; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 33947247925     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2006.12.018     Document Type: Article

References (27)

1. Elkharrat D., et al. Prévalence et prise en charge des infections urinaires communautaires. Etude prospective dans 78 SAU français. JEUR Suppl 17 (2004) 45
2. Foxman B., Klemstine K.L., and Brown P.D. Acute pyelonephritis in US hospitals in 1997: hospitalization and in-hospital mortality. Ann Epidemiol 13 (2003) 144-150
3. Elkharrat D., et al. Relevance in the emergency department of a decisional algorithm for outpatient care of women with acute pyelonephritis. Eur J Emerg Med 6 (1999) 15-20
4. Ferriere F. Procalcitonin, a new marker for bacterial infections. Ann Biol Clin (Paris) 58 (2000) 49-59
5. Dandona P., et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 79 (1994) 1605-1608
6. Meisner M., et al. Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Crit Care (Lond) 3 (1999) 45-50
7. Benador N., et al. Procalcitonin is a marker of severity of renal lesions in pyelonephritis. Pediatrics 102 (1998) 1422-1425
8. Gendrel D., et al. Measurement of procalcitonin levels in children with bacterial or viral meningitis. Clin Infect Dis 24 (1997) 1240-1242
9. Gendrel D., et al. Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs. viral infections. Pediatr Infect Dis J 18 (1999) 875-881
10. Suprin E., et al. Procalcitonin: a valuable indicator of infection in a medical ICU?. Intensive Care Med 26 (2000) 1232-1238
11. Pecile P., et al. Procalcitonin: a marker of severity of acute pyelonephritis among children. Pediatrics 114 (2004) e249-e254
12. Reith H.B., et al. Procalcitonin in early detection of postoperative complications. Dig Surg 15 (1998) 260-265
13. Whicher J., Bienvenu J., and Monneret G. Procalcitonin as an acute phase marker. Ann Clin Biochem 38 (2001) 483-493
14. Meisner M. Biomarkers of sepsis: clinically useful?. Curr Opin Crit Care 11 (2005) 473-480
15. Castelli G.P., et al. Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care 8 (2004) R234-R242
16. Martinot M., et al. Procalcitonin in pyelonephritis and acute community-acquired pneumonia in adults. Presse Med 30 (2001) 1091-1096
17. Chirouze C., et al. Low serum procalcitonin level accurately predicts the absence of bacteremia in adult patients with acute fever. Clin Infect Dis 35 (2002) 156-161
18. Miller II O., and Hemphill R.R. Urinary tract infection and pyelonephritis. Emerg Med Clin North Am 19 (2001) 655-674
19. Levy M.M., et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 29 (2003) 530-538
20. SPLF, antibiothérapie des infections urinaires; 2é conférence de consensus en thérapeutique anti-infectieuse. 1990.
21. Behr M.A., et al. Fever duration in hospitalized acute pyelonephritis patients. Am J Med 101 (1996) 277-280
22. Irwig L., et al. Designing studies to ensure that estimates of test accuracy are transferable. BMJ 324 (2002) 669-671
23. Knottnerus J.A., van Weel C., and Muris J.W. Evaluation of diagnostic procedures. BMJ 324 (2002) 477-480
24. Hausfater P., et al. Usefulness of procalcitonin as a marker of systemic infection in emergency department patients: a prospective study. Clin Infect Dis 34 (2002) 895-901
25. Chan Y.L., et al. Procalcitonin as a marker of bacterial infection in the emergency department: an observational study. Crit Care 8 (2004) R12-R20
26. Wanner G.A., et al. Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients. Crit Care Med 28 (2000) 950-957
27. Luyt C.E., et al. Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia. Am J Respir Crit Care Med 171 (2005) 48-53